FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, pharmaceutics, namely to medicinal form, which possesses prolonged action, which can be used for treatment of oropharyngeal zone. Composition for preparation of medicinal form includes medication which represents active substance or mixture of substance, sodium alginate, chitosan succinate, water-insoluble salt of Ca and Ba from series of stearates, palmitates, ozalates, tartrates, citrates, sulfates and carbonates, and water, in given in the invention formula quantities.
EFFECT: medications on invention have recommended themselves as convenient in application, which allow to increase efficiency of therapeutic process, reduce probability of development of allergic reactions.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING HYDROGEL OF MEDICINAL PURPOSE (VERSIONS) | 2010 |
|
RU2432954C1 |
| COMPOSITION FOR PREPARING DOSAGE FORM HAVING PROLONGED ACTION | 2012 |
|
RU2519723C1 |
| METHOD OF COMPOSITION CREATION FOR MEDICAL PREPARATION DELIVERY IN ORGANISM CAVITY AT DISEASES | 2007 |
|
RU2352359C1 |
| METHOD FOR PREPARING STERILE SELF-GELLING ALGINATE SYSTEM | 2013 |
|
RU2535035C1 |
| METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING MASS INCREASE, PROMOTING MASS REDUCTION, PROMOTING WEIGHT LOSS OR TREATING OR PREVENTING DIABETES FROM DEVELOPING | 2015 |
|
RU2745440C2 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
| METHOD FOR PREPARING THERAPEUTIC HYDROGEL | 2012 |
|
RU2508091C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | 2021 |
|
RU2780252C1 |
| PHARMACEUTICAL COMPOSITION 1-[2-(1-METHYLIMIDAZOL-4-YL)-ETHYL]PERHYDROAZINE-2,6-DIONE FOR THERAPY OF RESPIRATORY DISEASES | 2021 |
|
RU2823588C2 |
| COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
